Summary & Overview
CPT 36468: Sclerotherapy Injections for Spider Veins
CPT code 36468 identifies sclerotherapy for spider veins: single or multiple injections of a sclerosing solution administered to the arms, legs, or trunk. This procedure is a common, minimally invasive treatment in outpatient and office-based settings and is relevant for providers who manage cosmetic and therapeutic venous conditions. Nationally, sclerotherapy is significant for its role in phlebology practice patterns, patient access to minimally invasive vein care, and payer coverage policies that vary by clinical indication.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context, typical sites of service, and the service type associated with CPT code 36468. The publication also summarizes payer coverage considerations, common billing modifiers, and benchmarking information where available.
This resource is intended to help billing managers, coding professionals, and clinical administrators understand the clinical scope of CPT code 36468, how it is categorized for outpatient procedural billing, and what topics to review when aligning documentation and claims submission with payer policies. Data not available in the input is noted where applicable.
Billing Code Overview
CPT code 36468 describes the performance of a single or multiple injections of a sclerosing solution to treat spider veins of the arms, legs, or trunk. This service is a sclerotherapy procedure provided by a qualified clinician to induce closure of superficial telangiectasias and reticular veins.
Service type: Office-based or outpatient vascular/vein procedure, minimally invasive, injection-based therapy.
Typical site of service: Ambulatory surgical center, physician office, or outpatient clinic where phlebology or vascular procedures are performed.
Clinical & Coding Specifications
Clinical Context
A 42-year-old ambulatory female presents to an outpatient vascular clinic complaining of cosmetically bothersome spider veins on her lower legs. She has localized telangiectasias without significant venous reflux on duplex ultrasound. After a focused history and physical exam, the treating physician recommends sclerotherapy using a sclerosing solution injected directly into the spider veins. The procedure is performed in an office treatment room under topical antisepsis and sterile technique. The provider identifies target veins, prepares a foam or liquid sclerosant, and administers one or multiple injections until satisfactory blanching is achieved. The patient is monitored briefly post-procedure for adverse reactions, provided compression stocking instruction, and scheduled for a follow-up visit in 4–6 weeks for assessment and possible repeat treatment.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased Procedural Services | Use when work or resources substantially exceed usual requirements for sclerotherapy (e.g., unusually extensive treatment). |
23 | Unusual Anesthesia | Use when general anesthesia or deep sedation is required for medically necessary reasons during sclerotherapy. |